Effect of Chemoradiotherapy vs Chemotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer Controlled After 4 Months of Gemcitabine With or Without Erlotinib: The LAP07 Randomized Clinical Trial.
about
A current perspective on stereotactic body radiation therapy for pancreatic cancerEfficacy and safety of gemcitabine plus S-1 in pancreatic cancer: a pooled analysis of individual patient data.Correlation of 18F-Fluorodeoxyglucose Positron Emission Tomography Parameters with Patterns of Disease Progression in Locally Advanced Pancreatic Cancer after Definitive Chemoradiotherapy.Design, synthesis, and biological evaluation of novel EF24 and EF31 analogs as potential IκB kinase β inhibitors for the treatment of pancreatic cancerAssessment of treatment response during chemoradiation therapy for pancreatic cancer based on quantitative radiomic analysis of daily CTs: An exploratory studyPrognostic nomogram and score to predict overall survival in locally advanced untreated pancreatic cancer (PROLAP).From Clinical Standards to Translating Next-Generation Sequencing Research into Patient Care Improvement for Hepatobiliary and Pancreatic CancersPhase II study of induction chemotherapy followed by chemoradiotherapy in patients with borderline resectable and unresectable locally advanced pancreatic cancer.Induction Chemotherapy with Gemcitabine and Cisplatin Followed by Simultaneous Integrated Boost-Intensity Modulated Radiotherapy with Concurrent Gemcitabine for Locally Advanced Unresectable Pancreatic Cancer: Results from a Feasibility Study.Evolving treatment landscape for early and advanced pancreatic cancer.Phase II study of induction gemcitabine and S-1 followed by chemoradiotherapy and systemic chemotherapy using S-1 for locally advanced pancreatic cancer.Current and future therapies for advanced pancreatic cancer.Stereotactic body radiotherapy for unresected pancreatic cancer: A nationwide review.What treatment in 2017 for inoperable pancreatic cancers?Multiagent induction chemotherapy followed by chemoradiation is associated with improved survival in locally advanced pancreatic cancer.Charged-particle therapy in cancer: clinical uses and future perspectives.Outcomes for patients with locally advanced pancreatic adenocarcinoma treated with stereotactic body radiation therapy versus conventionally fractionated radiation.Change in carbohydrate antigen 19-9 level as a prognostic marker of overall survival in locally advanced pancreatic cancer treated with concurrent chemoradiotherapy.Stereotactic body radiotherapy for renal cell cancer and pancreatic cancer : Literature review and practice recommendations of the DEGRO Working Group on Stereotactic Radiotherapy.Having Your Cake and Eating It Too: Combining SBRT and Multi-agent Chemotherapy in Locally Advanced Pancreatic Cancer.Quantitative Proteomic Analysis of Serum Exosomes from Patients with Locally Advanced Pancreatic Cancer Undergoing Chemoradiotherapy.Biological determinants of radioresistance and their remediation in pancreatic cancer.Emerging protein kinase inhibitors for treating pancreatic cancer.Chemotherapy and intensity-modulated radiation therapy for locally advanced pancreatic cancer achieves a high rate of R0 resection.Surgical strategies and novel therapies for locally advanced pancreatic cancer.The Role of Consolidation Chemo-Radiotherapy in Locally Advanced Pancreatic Cancer Receiving Chemotherapy: An Updated Systematic Review and Meta-Analysis.Management of unresectable, locally advanced pancreatic adenocarcinoma.Pancreatic Ductal Adenocarcinoma: Current and Evolving Therapies.Stereotactic body radiation vs. intensity-modulated radiation for unresectable pancreatic cancer.[The results of the LAP07 trial should not be misunderstood as the end of chemoradiotherapy in pancreatic cancer].Reirradiation with stereotactic body radiation therapy after prior conventional fractionation radiation for locally recurrent pancreatic adenocarcinoma.Long-term results and recurrence patterns from SCALOP: a phase II randomised trial of gemcitabine- or capecitabine-based chemoradiation for locally advanced pancreatic cancer.Clinical Practice Guidelines for Cryosurgery of Pancreatic Cancer: A Consensus Statement From the China Cooperative Group of Cryosurgery on Pancreatic Cancer, International Society of Cryosurgery, and Asian Society of Cryosurgery.Proton beam reirradiation for locally recurrent pancreatic adenocarcinoma.Cutting Through Confusion: Multimodality Therapy in Borderline Resectable and Locally Advanced Pancreatic Cancer.Synergistic effect of a drug loaded electrospun patch and systemic chemotherapy in pancreatic cancer xenograft.Resection of Locally Advanced Pancreatic Neoplasms after Neoadjuvant Chemotherapy with Nab-Paclitaxel and Gemcitabine following FOLFIRINOX Failure.Dose-escalated radiotherapy for unresectable or locally recurrent pancreatic cancer: Dose volume analysis, toxicity and outcome of 28 consecutive patients.Dose escalation with an IMRT technique in 15 to 28 fractions is better tolerated than standard doses of 3DCRT for LAPC."HEATPAC" - a phase II randomized study of concurrent thermochemoradiotherapy versus chemoradiotherapy alone in locally advanced pancreatic cancer.
P2860
Q28077111-BA1DDBFA-D40F-497D-9B65-EDAB663E4B9EQ33441606-2D34109D-FF75-45F1-8957-C8748B24531BQ33676692-B6985675-4138-4F02-B96E-5B37B2396D45Q33713919-9B9DDB5C-9C76-402F-B5A6-44F97F9D2003Q36391055-96D3606D-0537-4726-B2CC-93BE5207F01BQ37151116-F935B6EE-74C0-4BB8-90D9-B046E5BEC6F9Q37631655-AAF31683-ACD1-42D6-9E40-7F12EF98B175Q37738012-B3BA083F-7869-47A7-B392-E63A1D3A023DQ38406521-ADD48523-C9CA-4DCA-BADC-F3EBBFAF709DQ38624806-7655065E-53C3-479E-BC44-7A1095AAB0A3Q38673039-3BBEE0C9-66E5-41A1-9F50-2317788A196FQ38673621-C1688A55-FCEF-4300-A9CF-A6DC664C7DFFQ38678790-BC41EF1E-D157-4CB9-B743-C8259C70749CQ38689025-9D422573-F1B4-43D4-8925-443A46615A2AQ38722475-C3ACF3B7-367F-4AF4-8CA6-A4DD65EC022BQ38746213-E10C0965-10A7-4C6C-8E9B-4EFB5F78172CQ38792423-159B4062-0BB7-4C48-AD00-11A00E346588Q38801235-9E844138-5461-40F1-8E07-25B0D83AE057Q38806110-78293393-8378-4FC3-BCB3-885088737675Q38935821-7F742E4C-6890-45EA-A07A-0C7E923BB6A1Q38939835-94F13CC0-062A-46DE-8CE7-39E98EA6DD4EQ39156722-25950E36-442B-4FC9-8C13-0DD39E3502DEQ39158411-59E32B63-DA9E-4E10-9EE2-D47F0C26EB72Q39234276-674FE2DD-D7A7-4086-958D-922BCB9C43C9Q39312912-F2C43D5E-AAA6-4192-B9EF-E965CB533F47Q39364761-8349171E-67CC-48F2-AE01-C119919A7D4AQ39371353-EED65AC1-9A57-4D0B-AA7E-C3A564DF23A8Q39390859-6FBD03B7-B48E-463F-8879-A247D672A7A4Q40141235-E70FB365-CA14-4D6D-B5FB-00C9D54F5C1FQ40531561-DDEF5756-36B5-4CF8-9C43-23739FE472CCQ41039836-32EBDDB4-A2EB-4136-A3BE-1E2692947633Q41055466-7A0FDE83-BB97-47D9-B60F-81D4B1850EB9Q41386937-6023CE72-F7C5-4429-9723-3A16F2460DBAQ41598639-41E3ECC7-2CE1-490F-AB8D-236BFCA6C0F1Q41651225-A255060F-0B44-4732-A03F-59C05605410BQ42366470-EC2B0017-3AC2-4DC6-923F-CD9D0A8775F8Q42368801-2C34E7D0-0C08-4FEA-9ABF-6E07AAAB9A7EQ42375843-16C1C33E-F1A8-4D82-A0B4-D8FE27B523DFQ43379696-0ED34158-F401-4678-A111-7256DBD04369Q47107002-592475FF-DBED-415E-837F-F3D547C937A8
P2860
Effect of Chemoradiotherapy vs Chemotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer Controlled After 4 Months of Gemcitabine With or Without Erlotinib: The LAP07 Randomized Clinical Trial.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Effect of Chemoradiotherapy vs ...... P07 Randomized Clinical Trial.
@en
type
label
Effect of Chemoradiotherapy vs ...... P07 Randomized Clinical Trial.
@en
prefLabel
Effect of Chemoradiotherapy vs ...... P07 Randomized Clinical Trial.
@en
P2093
P921
P356
P1476
Effect of Chemoradiotherapy vs ...... AP07 Randomized Clinical Trial
@en
P2093
Bengt Glimelius
Benoist Chibaudel
Christophe Louvet
David Goldstein
Florence Huguet
Franck Bonnetain
Ivan Borbath
Jean-Luc van Laethem
Jenny Shannon
LAP07 Trial Group
P304
P356
10.1001/JAMA.2016.4324
P407
P577
2016-05-01T00:00:00Z